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Abstract. 
 
We puriﬁed native WASp (Wiskott-Aldrich
Syndrome protein) from bovine thymus and studied its
ability to stimulate actin nucleation by Arp2/3 complex.
WASp alone is inactive in the presence or absence of
 
0.5 
 
m
 
M GTP-Cdc42. Phosphatidylinositol 4,5 bisphos-
phate (PIP
 
2
 
) micelles allowed WASp to activate actin
nucleation by Arp2/3 complex, and this was further en-
hanced twofold by GTP-Cdc42. Filaments nucleated by
Arp2/3 complex and WASp in the presence of PIP
 
2
 
 and
Cdc42 concentrated around lipid micelles and vesicles,
providing that Cdc42 was GTP-bound and prenylated.
Thus, the high concentration of WASp in neutrophils (9
 
m
 
M) is dependent on interactions with both acidic
lipids and GTP-Cdc42 to activate actin nucleation by
Arp2/3 complex. The results also suggest that mem-
brane binding increases the local concentrations of
Cdc42 and WASp, favoring their interaction.
Key words: prenylation • membrane • GBD • neutro-
phil • thymus
 
Introduction
 
Arp2/3 complex (Machesky et al., 1994) initiates the
barbed end growth of actin filaments by enhancing their
nucleation (Mullins et al., 1998). Filaments initiated by
Arp2/3 complex grow from the sides of other actin fila-
ments to form branches in a process termed dendritic nu-
cleation. Dendritic nucleation occurs at the leading edge
of motile cells, and Arp2/3 complex localizes to branch
points (Bailly et al., 1999; Svitkina and Borisy, 1999). The
importance of Arp2/3 complex for actin dynamics in gen-
eral is supported by work in diverse organisms including
the following: mammalian tissue culture cells (Machesky
et al., 1997; Welch et al., 1997a; Machesky and Insall, 1998)
and lymphocytes (Weiner et al., 1999); extracts from brain
(Ma et al., 1998b) and 
 
Acanthamoeba
 
 (Mullins and Pol-
lard, 1999); and genetics in both budding (Winter et al.,
1999b) and fission yeast (Balasubramanian et al., 1996;
McCollum et al., 1996; Morrell et al., 1999).
Highly purified Arp2/3 complex alone does not enhance
actin nucleation unless activated by members of the
WASp/Scar protein family (Higgs et al., 1999; Machesky et
al., 1999; Rohatgi et al., 1999; Winter et al., 1999a; Yarar et
al., 1999) or bacterial proteins (Welch et al., 1998). Activa-
tion by WASp/Scar proteins requires only their COOH-
terminal 70–100 amino acids, termed the WA region (see
Fig. 1 A). WA contains an actin-binding WH2 motif, an
Arp2/3 complex–binding COOH-terminal acidic motif,
and a connecting region in between, which might contrib-
ute to activation (Marchand et al., 2000). 
Mammals have genes for at least five WASp/Scar pro-
teins (for review see Higgs and Pollard, 1999). Wiskott-
Aldrich Syndrome protein (WASp)
 
1
 
 appears to be re-
stricted to hematopoietic cells and mutations to the WASp
gene can cause Wiskott-Aldrich Syndrome, causing de-
fects in platelets and lymphocytes (Ochs, 1998). N-WASP
is closely related in sequence to WASp and is more widely
expressed (Miki et al., 1996). Less is known about the
three Scar isoforms, also called WAVE (Suetsugu et al.,
1999).
WA regions of WASp/Scar proteins constitutively acti-
vate Arp2/3 complex. The NH
 
2
 
-terminal 85% of these pro-
teins contain sequences capable of interacting with many
other proteins including the following: the Rho family GTP-
ase, Cdc42; Src family tyrosine kinases; Tec family tyrosine
kinases; the adaptor proteins, Nck and Grb2; and calmod-
ulin (for review see Higgs and Pollard, 1999). An attrac-
tive model for WASp regulation (Miki et al., 1998; Kim et
al., 2000) is that the NH
 
2
 
-terminal region autoinhibits the
COOH-terminal WA region, and binding of regulatory
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proteins to NH
 
2
 
-terminal sequences relieves this inhibition,
resulting in Arp2/3 complex activation and actin nuclea-
tion. The lipid second messenger, phosphatidylinositol-4,5-
bisphosphate (PIP
 
2
 
), also might bind WASp and N-WASP
and might assist in activation (Rohatgi et al., 1999).
Several lines of evidence support the model that GTP-
bound Cdc42 (GTP-Cdc42) activates WASp or N-WASP
by relief of autoinhibition. GTP-Cdc42 strongly stimulates
actin nucleation in resting cell extracts (Zigmond et al.,
1997; Ma et al., 1998a; Mullins and Pollard, 1999). Nuclear
magnetic resonance structures show that GTP-Cdc42 binds
a specific region (GTPase binding domain or GBD) on
WASp and N-WASP (Abdul-Manan et al., 1999). WASp-
WA also binds to WASp GBD, and GTP-Cdc42 competes
for this binding site (Miki et al., 1998; Kim et al., 2000). Fi-
nally, Cdc42 enhances the ability of full-length recombi-
nant N-WASP to activate Arp2/3 complex in vitro, an ef-
fect which is enhanced by PIP
 
2
 
 (Rohatgi et al., 1999).
However, results obtained using recombinant full-length
WASp or N-WASP to activate Arp2/3 complex in vitro
are inconsistent. First, in all published experiments, WASp
or N-WASP displayed considerable Arp2/3 complex acti-
vation ability in the absence of Cdc42, ranging from full
constitutive activity of WASp (Yarar et al., 1999) to partial
activity of N-WASP (Egile et al., 1999; Rohatgi et al.,
1999). Second, Rohatgi et al. (1999) found that both GTP-
and GDP-Cdc42 activated N-WASP, whereas Egile et al.
(1999) showed that only GTP-Cdc42 was activated. Fi-
nally, lipid modification of Cdc42 varied in these studies as
Rohatgi et al. (1999) used insect cell–expressed, prenyl-
ated Cdc42, whereas Egile et al. (1999) used 
 
Escherichia
coli
 
–expressed, unprenylated Cdc42. Both forms stimu-
lated N-WASP. Attention to prenylation is significant
since studies with cell extracts suggest that prenylated
Cdc42 is required to activate actin polymerization (Zig-
mond et al., 1997; Ma et al., 1998a).
These inconsistencies leave open many questions re-
garding the mechanism of WASp or N-WASP activation
by Cdc42. In principle, autoinhibition should be very tight
to prevent activation of Arp2/3 complex in the absence of
GTP-Cdc42, as observed in cell extracts. Also, the require-
ment for GTP-bound Cdc42 should be absolute since ex-
periments in both whole cells and cell extracts suggest that
GDP-Cdc42 is inactive (Nobes and Hall, 1995; Zigmond et
al., 1997). For these reasons, we purified native WASp for
the first time and studied its ability to activate Arp2/3
complex in the presence and absence of Cdc42 and PIP
 
2
 
.
We find that the regulation of WASp by PIP
 
2
 
 and GTP-
Cdc42 is robust, with WASp being inactive in their ab-
sence. PIP
 
2
 
 alone stimulates WASp, whereas GTP-Cdc42
alone does not. However, GTP-Cdc42 does augment PIP
 
2
 
stimulation. This augmentation requires that Cdc42 be
both GTP-bound and prenylated. The synergy between
PIP
 
2
 
 and GTP-Cdc42 causes WASp-mediated actin nucle-
ation on lipid surfaces.
 
Materials and Methods
 
Protein Preparation
 
We purified Arp2/3 complex from bovine thymus following the method
described in Higgs et al. (1999). Rabbit skeletal muscle actin was purified
 
from acetone powder (Spudich and Watt, 1971), gel filtered (MacLean-
Fletcher and Pollard, 1980), and labeled with pyrenyliodoacetamide (Pol-
lard and Cooper, 1984).
GST WASp-WA and WASp-WA were prepared as previously de-
scribed (Higgs et al., 1999). WASp152-309 was produced by expression in
PET15b (Novagen), purification by nickel-NTA affinity chromatography
(QIAGEN), and cleavage of the 6xHis tag with thrombin. Human Cdc42
was expressed in SF9 cells as a glutathione-S-transferase (GST) fusion
protein in pAcGHLT (PharMingen) using the baculovirus expression sys-
tem, and was purified from the membrane fraction by glutathione-
Sepharose affinity chromatography with subsequent cleavage of the GST
moiety (Heyworth et al., 1993). Human Cdc42 was expressed in 
 
E. coli 
 
as
a GST fusion protein in pGEX-2T, and purified from the nonmembrane
fraction by glutathione-Sepharose affinity chromatography and cleavage
of GST (Heyworth et al., 1993). Cdc42 was charged with GTP
 
g
 
S or
GDP
 
b
 
S by incubating 50 
 
m
 
M Cdc42 with 2.7 mM nucleotide in 10 mM
Tris-HCl, pH 7.5, 1 mM DTT, 3 mM diethylenetrinitrilo-pentaaacetic
acid, 0.5 mM MgCl
 
2
 
 for 10 min at 30
 
8
 
C. MgCl
 
2
 
 was added to 4 mM, the
mixture was kept on ice and used within 2 h. This nucleotide exchange
procedure was used because the high concentration of EDTA used in
other procedures (Heyworth et al., 1993) accelerated actin polymerization
from monomers in the pyrene-actin assay.
 
Antibody Production
 
The WASp 209-226 peptide was synthesized with an added cysteine resi-
due at its NH
 
2 
 
terminus on an Applied Biosystems 432A peptide synthe-
sizer and coupled to keyhole limpet hemocyanin following instructions
from the Pierce Chemical Co. This material was used to raise polyclonal
antiserum in New Zealand white rabbits. AB1 was affinity-purified from
serum using 209–226 peptide immobilized on Sulfolink gel (Pierce Chemi-
cal Co.).
 
WASp Concentration in Human Polymorphonuclear 
Leukocytes (PMN)
 
Human PMN were isolated from freshly drawn blood from healthy donors
(The General Clinical Research Center, Scripps Research Institute) in
ACD (Higgs et al., 1999). The cell number was determined using a hema-
cytometer. Cells (final concentration, 2.3 
 
3
 
 10
 
4
 
 cells/
 
m
 
l) were added to
boiling SDS-PAGE sample buffer and were boiled for 5 min. Protein con-
centration was 1 mg/ml by Bradford assay on a parallel sample diluted
into 0.1% Thesit (Roche Biochemicals). The sample in SDS-PAGE buffer
was diluted to various concentrations in the absence or presence of vari-
ous concentrations of WASp152-309 in SDS-PAGE buffer. Samples were
separated by SDS-PAGE and analyzed by Western blotting against AB1
with chemiluminescence detection. The integrated densities of the WASp
and WASp152-309 bands were determined using NIH Image 1.60/ppc.
Signals were linear for WASp between 1 and 10 
 
m
 
g PMN homogenate,
and for WASp152-309 between 2.5 and 20 ng in a background of 5 
 
m
 
g
PMN homogenate (44 pg protein/PMN determined by Bradford assay).
WASp was determined to be 10.2 ng in 5 
 
m
 
g PMN homogenate from the
WASp152-309 standard curve. WASp in 2.5 and 7.5 
 
m
 
g PMN homogenate
was 4.8 and 16.2 ng, respectively. WASp concentration in PMN cytoplasm
was determined using 1.8 
 
3
 
 10
 
2
 
13
 
 liters/cell, in which the nuclear and gran-
ule volumes have been subtracted from the total cell volume (Ting-Beall
et al., 1993).
 
WASp Purification
 
All steps were carried out at 4
 
8
 
C or on ice. All chromatographic supplies
were purchased from Amersham Pharmacia Biotech. Six frozen bovine
calf thymi (PelFreeze) were broken into small bits with a hammer, and ho-
mogenized in a blender followed by a Polytron (Bransonic) in 1 ml/g of
EB (40 mM Tris-HCl, pH 8.0, 5 mM EGTA, 1 mM MgCl
 
2
 
, 1 mM DTT, 1
mM PMSF, 20 
 
m
 
g/ml leupeptin, 6 
 
m
 
g/ml pepstatin A). The homogenate
was centrifuged at 11,000
 
 g
 
 for 15 min, and the resulting supernatant was
centrifuged at 100,000
 
 g
 
 for 1 h to obtain a high speed supernatant (HSS).
The conductivity of the HSS was adjusted to the equivalent of QA (20
mM Tris-HCl, pH 8.0, 100 mM NaCl, 1 mM EGTA, 1 mM MgCl
 
2
 
, 1 mM
DTT, 2 
 
m
 
g/ml leupeptin, 2 
 
m
 
g/ml pepstatin A) with solid NaCl. The HSS
was loaded onto 300 ml of Q Sepharose Fast Flow, and WASp was eluted
with 3,000 ml of linear gradient to QB (QA 
 
1 
 
200 mM NaCl). Fractions
containing full-length WASp (by Western blot) were pooled and solid am-
monium sulfate (GIBCO BRL) was added to 40% saturation (243 g/liter) 
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with vigorous mixing. After 15 min, the sample was centrifuged at 10,000
rpm for 15 min, and the pellet was redissolved in PB (20 mM Tris-HCl, pH
8.0, 1 mM EGTA, 1 mM MgCl
 
2
 
, 1 mM DTT). The conductivity was ad-
justed to the equivalent of PA (PB 
 
1 
 
1,000 mM NaCl), and the sample
was loaded onto 50 ml of phenyl-Sepharose high performance equili-
brated with PA. WASp was eluted with a linear gradient to PB. WASp-
containing fractions were pooled, dialyzed against SA (10 mM Pipes, pH
6.8, 50 mM NaCl, 1 mM EGTA, 1 mM MgCl
 
2
 
, 1 mM DTT), and loaded
onto a MonoS 10/10 column equilibrated in SA. WASp was eluted with a
linear gradient from SA to SB (SA 
 
1 
 
500 mM NaCl). WASp-containing
fractions were pooled and loaded onto a 1.6 
 
3
 
 60-cm Superdex200 column
equilibrated in QA. WASp-containing fractions were pooled and concen-
trated by loading onto a MonoQ5/5 column equilibrated in QA and elut-
ing with a linear gradient to QB. Sedimentation equilibrium ultracentrifu-
gation of 40 nM bovine WASp in 10 mM imidazole, pH 7.0, 50 mM KCl, 1
mM MgCl
 
2
 
, 1 mM EGTA, and 1 mM DTT at 23
 
8
 
C was carried out in a
Beckman Optima XL-I. WASp sedimentation was monitored at 225 nm.
Distributions of WASp at equilibrium were fitted using the nonlinear least
squares method of Winnonln (Johnson et al., 1981).
 
Actin Polymerization by Fluorescence Spectroscopy
 
A detailed procedure is described in Higgs et al. (1999). Reactions con-
tained 4 
 
m
 
M Mg-ATP actin (5% pyrene-labeled), 10 mM imidazole, pH
7.0, 50 mM KCl, 1 mM EGTA, and 1 mM MgCl
 
2
 
 in G buffer-Mg (2 mM
Tris-HCl, pH 8.0, 0.5 mM DTT, 0.2 mM ATP, 0.1 mM MgCl
 
2
 
, 0.02% wt/
vol NaN
 
3
 
). When used, PIP
 
2
 
 was added from a 2-mM stock in water.
Pyrene fluorescence data (excitation at 365 nm and emission at 407 nm)
were collected on a PTI AlphaScan spectrofluorometer (Photon Technol-
ogy International) at a rate of 1 point/s. The concentration of filament
ends (Ends) was determined at the point on the polymerization curve at
which 80% of the actin had polymerized because few filaments form after
this point (Higgs et al., 1999).
 
Phospholipid Vesicles
 
All phospholipids were suspended in chloroform and purchased from
Avanti Polar Lipids including the following: egg phosphatidylcholine
(PC); egg phosphatidylethanolamine (PE); brain phosphatidylserine (PS);
brain phosphatidylinositol (PI); egg phosphatidic acid (PA); brain PIP
 
2
 
;
carboxyfluorescein-labeled PE (CF-PE); and cholesterol. For microscopy,
lipids were mixed in the appropriate quantities, and the chloroform was
removed under vacuum. The lipid film was resuspended in 10 mM imida-
zole, pH 7.0, 50 mM KCl, 1 mM EGTA, 1 mM MgCl
 
2
 
 by vortexing, and
subjected to five freeze/thaw cycles in dry ice/ethanol and a 37
 
8
 
C water
bath. For vesicle pelleting assays, the same procedure was followed ex-
cept: 0.05% di-bodipy-PC (Molecular Probes) was added to the lipids; 170
mM sucrose was added to the resuspension buffer; and the vesicles were
extruded 10 times through 0.1-
 
m
 
m pore size polycarbonate filters (Lipex).
Pelleting assays were conducted by mixing 2 
 
m
 
M WASp152-309 with uni-
lamellar vesicles (500 
 
m
 
l total lipid) for 5 min at 23
 
8
 
C, and then centrifug-
ing in a TLA-100 rotor (Beckman Coulter) for 15 min at 90,000 rpm. For
all lipid mixtures, 
 
.
 
99% of the lipid was in the pellet as judged by the de-
pletion of di-bodipy-PC fluorescence from the supernatant. Pellets and su-
pernatants were analyzed by SDS-PAGE and Coomassie staining.
 
Fluorescence Microscopy
 
Nucleation reactions were initiated as described above with 4 
 
m
 
M
rhodamine-labeled phalloidin (Sigma Chemical Co.). After incubation at
23
 
8
 
C for 20 min, reactions were diluted either 625-fold (micelle experi-
ments) or 25-fold (vesicle experiments) into microscopy buffer (50 mM
KCl, 1 mM MgCl
 
2
 
, 100 mM DTT, 20 
 
m
 
g/ml catalase, 100 
 
m
 
g/ml glucose ox-
idase, 3 mg/ml glucose, 0.5% methylcellulose, 10 mM imidazole, pH 7.0).
Diluted sample (2 
 
m
 
l) was applied to coverslips coated with 0.1% nitrocel-
lulose, and fluorescence was viewed with an Olympus X-70 microscope
(Blanchoin et al., 2000).
 
Fluorescence Anisotropy
 
Experiments were conducted as previously described (Blanchoin and Pol-
lard, 1998; Vinson et al., 1998). In brief, 0.1 
 
m
 
M of rhodamine-labeled
WASp WA and varying concentrations of binding partners were incu-
bated in 10 mM imidazole, pH 7.0, 50 mM KCl, 1 mM MgCl
 
2
 
, 1 mM
EGTA, and 0.025% Thesit (Roche Biochemicals) for 10 min at 23
 
8
 
C. Flu-
orescence anisotropy was measured in an AlphaScan spectrofluorometer
(Photon Technologies International) at 552 nm excitation and 574 nm
emission.
 
Results
 
Characterization of Antibodies Against WASp
 
Antibodies against a peptide consisting of residues 209–226
of human WASp, a region with no significant homology to
N-WASP or Scar proteins, recognized a 65-kD band in
lysates of human neutrophils and bovine thymus (Fig. 1
B). Although the calculated molecular mass of WASp is
Figure 1. Extraction and purification of WASp from leukocytes.
(A) Schematic diagram of WASp with the domains and con-
structs used in this study. (B) Extraction of WASp. Homogenates
(Homog.) from human peripheral neutrophils and bovine thymus
were fractionated into a 4,000-g pellet (LSP), 100,000-g pellet
(HSP), and 100,000-g supernatant (HSS). 10 mg of the total ho-
mogenate and equal volumes of the centrifuged fractions were
Western blotted with AB1. (C) Determination of WASp concen-
tration in human neutrophils. SDS-PAGE of homogenates at
various dilutions in the absence or presence of varying concentra-
tions of WASp152-309. Western blots against AB1 were analyzed
by densitometry. (D) Gel filtration of purified WASp on
Superdex200 in 10 mM imidazole, pH 7.0, 50 mM KCl, 1 mM
MgCl2, 1 mM EGTA, and 1 mM DTT. The concentrations of
WASp in the eluted fractions were measured by quantitative
Western blotting. (inset) Coomassie blue–stained SDS-PAGE of
0.2 mg purified WASp before gel filtration. 
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53,041 D, migration of the band at 65 kD agrees with pre-
vious studies (Zhu et al., 1996). WASp from thymus mi-
grated as a doublet, which might be due to limited proteol-
ysis or to posttranslational modification. AB1 also reacted
with several lower molecular mass bands, the most promi-
nent in thymus at 40 kD, which varied in intensity between
preparations. Several of these bands may be proteolytic
fragments of full-length WASp since they were reduced by
stringent regimes of protease inhibitors and they increased
in lysates over time as the full-length WASp band de-
creased.
Most of the full-length WASp in these lysates parti-
tioned into the 100,000
 
-g
 
 supernatant, with minor amounts
in the 4,000
 
-g
 
 pellet and 100,000
 
-g
 
 pellet (Fig. 1 B). The
concentration of WASp in PMN cytoplasm was deter-
mined to be 9
 
 6 
 
2 
 
m
 
M (Fig. 1 C), a value similar to the
concentration of Arp2/3 complex in PMN (Higgs et al.,
1999).
 
Purification and Physical Properties of WASp
 
We purified WASp from the 100,000
 
-g
 
 supernatant of bo-
vine calf thymus by anion exchange chromatography, am-
monium sulfate precipitation, phenyl-Sepharose chroma-
tography, and cation exchange chromatography, assessing
purification steps by Western blotting. Although the yield
of WASp was consistent among three preparations (8, 10,
and 14 
 
m
 
g), the purity varied. After SDS-PAGE, one prep-
aration yielded only one visible band by Coomassie stain-
ing (Fig. 1 D, inset). The other two preparations contained
minor contaminating bands, none of which reacted with
AB1. Purified WASp from all preparations had a Stokes’
radius of 5.0 nm on Superdex 200 gel filtration chromatog-
raphy (Fig. 1 D), which is considerably larger than that ex-
pected for a globular protein of 55 kD. By sedimentation
equilibrium analytical ultracentrifugation, 40 nM native
WASp had a molecular mass of 122 kD (not shown). The
data were noisy owing to the low concentration of WASp,
but rule out a monomer. Larger quantities will be required
to determine if WASp is a dimer or a trimer.
We also attempted to purify the WASp expressed in in-
sect cells using the baculovirus infection system. Despite
good expression, we were unable to recover purified
WASp using the native WASp purification procedure. A
majority of recombinant WASp pelleted at low speed in
the extract, and remained insoluble upon detergent and
salt treatment. Furthermore, the WASp expressed in in-
sect cells eluted heterogeneously from all columns, in con-
trast to the native WASp, which eluted as a single peak
from each column. One possibility is that the WASp ex-
pressed in insect cells was in heterogeneous aggregates
that caused it to fractionate poorly.
 
Effect of WASp, Cdc42, and PIP
 
2
 
 on Actin Nucleation 
through Arp2/3 Complex
 
We tested the ability of full-length WASp to activate actin
nucleation through Arp2/3 complex using fluorescence of
pyrene-actin to follow the polymerization time course.
WASp alone (4 nM) or with 10 nM Arp2/3 complex had
no effect on the time course of actin polymerization (Fig. 2
A). The addition of 500 nM GTP
 
g
 
S-Cdc42 to WASp and
Arp2/3 complex did not alter the polymerization time
course. However, addition of PIP
 
2
 
 micelles to WASp and
Arp2/3 complex accelerated polymerization and produced
12-fold more filaments (Fig. 2, A and B, and Table I). The
addition of GTP
 
g
 
S-Cdc42 doubled the effect of PIP
 
2
 
alone. This synergy between PIP
 
2
 
 and Cdc42 required
GTP
 
g
 
S and recombinant Cdc42 from insect cells, which
contained the prenyl modification (prenylated Cdc42). The
Cdc42 expressed in 
 
Escherichia coli
 
 (unprenylated Cdc42)
was inactive, as was prenylated GDP
 
b
 
S-Cdc42 (Table I).
The effects of PIP
 
2
 
 and prenylated GTP
 
g
 
S-Cdc42 required
Arp2/3 complex and WASp. Neither PIP
 
2
 
 nor prenylated
GTP
 
g
 
S-Cdc42 changed the ability of WASp WA, the con-
stitutively active COOH-terminal 70 residues of WASp, to
activate Arp2/3 complex (not shown).
The degree to which WASp activated Arp2/3 complex
Figure 2. Activation of Arp2/3 complex by native WASp and
WASp-WA. (A) Effect of Cdc42 and PIP2 on WASp activation
of Arp2/3 complex. Monomeric MgATP actin (4 mM, 5%
pyrene-labeled) was polymerized in the presence of 10 nM of
Arp2/3 complex and no addition (open circles), 4 nM WASp
(filled circles), 4 nM WASp, and 500 nM prenylated GTPgS-
Cdc42 (open diamonds), 4 nM WASp, and 20 mM PIP2 micelles
(open squares), 4 nM WASp, 20 mM PIP2 micelles and 500 nM
prenylated GTPgS-Cdc42 (filled triangles), and 500 nM WASp
WA (crosses). (B) Dependence of nucleation by Arp2/3 complex
and native WASp on PIP2 concentration. Conditions were as de-
scribed in A, with 4 nM WASp and a varying concentration of
PIP2 in the absence of Cdc42. The concentration of filament ends
was calculated from the slopes of polymerization curves at 80%
polymerization. (C) Dependence of nucleation by Arp2/3 com-
plex on the concentrations of dimeric GST-WA (closed circles)
or monomeric WASp-WA (open circles). Conditions are as in A,
except no PIP2 or Cdc42 was added. 
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in the absence of prenylated GTP
 
g
 
S-Cdc42 and PIP
 
2
 
 var-
ied slightly among the three WASp preparations. Two of
the preparations displayed no activation ability, whereas
the third stimulated a twofold increase in filaments nucle-
ated in the absence of activators. However, all three prep-
arations responded in near identical fashion to activation
by PIP
 
2
 
 and prenylated GTP
 
g
 
S-Cdc42.
Native WASp was remarkably active in the presence of
PIP
 
2
 
 and prenylated GTPgS-Cdc42. At 4 nM, WASp gen-
erated 3-nM filaments (Table I). At the same concentra-
tion, WASp-WA had no detectable effect on polymeriza-
tion (Fig. 2 C). To investigate whether the multimeric state
of full-length WASp contributes to this high activity, we
tested dimeric GST WASp-WA. Dimeric GST-WA was
almost 100-fold more efficient at activating Arp2/3 com-
plex than monomeric WA, resulting in activation similar
to activated native WASp (Fig. 2 C).
Actin Networks Generated by WASp and
Arp2/3 Complex
We next examined the effect of WASp on Arp2/3 com-
plex–mediated actin networks by fluorescence microscopy
(Blanchoin et al., 2000). In the presence of Arp2/3 com-
plex, WASp alone (from the partially active preparation)
induced a greater number of shorter filaments than Arp2/3
complex alone (Fig. 3 C and Table II), but created few
branches. The addition of prenylated GTPgS-Cdc42 did
not change filament length or the degree of branching
(Fig. 3 E and Table II). The addition of PIP2 to WASp and
Arp2/3 complex dramatically increased the number of
branches and reduced the mean filament length (Fig. 3 D
and Table II) because of the more complete activation of
Arp2/3 complex by the limiting quantity of WASp (Higgs
et al., 1999; Blanchoin et al., 2000). PIP2 and prenylated
GTPgS-Cdc42 with WASp and Arp2/3 complex produced
highly fluorescent halos of actin filaments (Fig. 3 F). These
halos, which were much larger (diameter of 7.2 6 3.1 mm,
n 5 25) than the 10-nm diam PIP2 micelles, did not repre-
sent the majority of the polymerized actin, but were
clearly sites of intense nucleation. Unprenylated GTPgS-
Cdc42 did not generate actin filament halos with PIP2,
WASp, and Arp2/3 complex (not shown). Because of the
intense fluorescence of the halos, individual filaments
were hard to resolve. Those that could be resolved were
not heavily branched, and the branches were oriented ran-
domly with respect to the halo (out of six discernible
branches, three branched toward the halo and three away
from it). The halos were unstable and rapidly shed fila-
ments upon prolonged exposure to the halogen lamp,
sometimes resulting in exploding halos. The shed fila-
ments were short (,2 mm) and highly branched. Filaments
distant from the halos appeared to exist in two popu-
lations: long unbranched filaments and short branched fil-
aments (Table II). These results suggest that aggregates
consisting of PIP2 micelles and prenylated GTPgS-Cdc42
serve as activation centers for WASp. These effects de-
pended on both GTPgS and prenylation of Cdc42.
Multilamellar vesicles containing 10% PIP2 also stimu-
lated the formation of filament-rich halos, providing pre-
nylated GTPgS-Cdc42 was also present (Fig. 3 H). These
halos of actin filaments, similar in size (8.1 6  3.8–mm
diam, n 5 52) to those forming around micelles, had a ves-
icle at their core, revealed using vesicles containing 5%
fluorescein-PE (Fig. 3 H, inset). Only z10% of the
fluorescent vesicles were surrounded by actin, possi-
bly because of nonuniform distribution of prenylated
GTPgS-Cdc42 on the vesicles. In contrast to the micelle
experiments, most of the fluorescent actin filaments were
associated with vesicles. Few filaments were .20  mm
from the filament-encircled vesicles. Filaments dissoci-
ated from the halos over time (not shown), suggesting
that filaments not associated with vesicles were probably
nucleated from the vesicle and then dissociated. Actin fil-
aments also polymerized around PS-containing vesicles
in the presence of GTPgS-Cdc42-BV, WASp, and Arp2/3
complex (Fig. 3 G). Although the mean sizes of these ac-
tin-containing structures were comparable (7.4 6 3.7 mm,
n 5 11), they were 40-fold less abundant than the actin-
surrounded PIP2 vesicles and did not represent the ma-
jority of polymerized actin. PIP2-containing vesicles with
WASp and Arp2/3 complex without Cdc42 produced
many short, highly branched filaments (not shown), indi-
cating increased actin nucleation. However, these actin
filaments did not cluster around vesicles. In summary,
both prenylated GTPgS-Cdc42 and PIP2 were required
to produce actin filament–rich foci around micelles and
vesicles.
Table I. Effect of WASp Activators on Actin Nucleation by WASp and Arp2/3 Complex
Conditions
Concentration
ends
Relative 
concentration ends
 nM
Actin 0.13 1
Actin, Arp2/3 complex 0.13 1
Actin, Arp2/3 complex, WASp 0.15 1.2
Actin, Arp2/3 complex, WASp, PIP2 1.57 12.1
Actin, Arp2/3 complex, WASp, prenylated GTPgS-Cdc42 0.15 1.2
Actin, Arp2/3 complex, WASp, PIP2, prenylated GTPgS-Cdc42 2.99 23.0
Actin, Arp2/3 complex, WASp, PIP2, unprenylated GDPbS-Cdc42 1.55 12.1
Actin, Arp2/3 complex, WASp, PIP2, unprenylated GTPgS-Cdc42 1.08 8.3
Actin, Arp2/3 complex, WASp-WA 7.50 57.7
Reagent concentrations: 4 mM actin, 10 nM Arp2/3 complex, 4 nM WASp, 20 mM PIP2, 0.5 mM Cdc42, and 1 mM WASp-WA. Concentration ends were determined at 80%
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Figure 3. Fluorescence mi-
crographs of the products of
actin polymerization reac-
tions. Polymerization reac-
tions contained 4 mM mono-
meric MgATP actin, with or
without 100 nM of Arp2/3
complex, 4 nM WASp, 0.5
mM prenylated GTPgS-
Cdc42, 22 mM PIP2 micelles,
or 100 mM of phospholipid
vesicles. After polymeriza-
tion for 20 min at 238C in
KMEI containing 4 mM
rhodamine-phalloidin, sam-
ples were diluted 625-fold
(A–F) or 25-fold (G and H)
into motility buffer, mounted
on nitrocellulose-coated cov-
erslips, and viewed with fil-
ters for rhodamine. (A)
Arp2/3 complex, prenylated
GTPgS-Cdc42, PIP2 micelles,
(B) WASp, prenylated
GTPgS-Cdc42, PIP2 mi-
celles, (C) Arp2/3 complex,
WASp, (D) Arp2/3 com-
plex, WASp, PIP2 micelles,
(E) Arp2/3 complex, WASp,
prenylated GTPgS-Cdc42, (F)
Arp2/3 complex, WASp, pren-
ylated GTPgS-Cdc42, PIP2
micelles, (G) Arp2/3 com-
plex, WASp, prenylated
GTPgS-Cdc42, multilamel-
lar vesicles containing 50%
cholesterol/14.5% PC/14.5%
PE/20% PS/1% CF-PE, or
(H) Arp2/3 complex, WASp,
prenylated GTPgS-Cdc42,
multilamellar vesicles con-
taining 50% cholesterol/
19.5% PC/19.5% PE/10%
PIP2/1% CF-PE. Inset in G
shows corresponding fluores-
cein image of G, showing the
vesicle at the interior of the
actin halo (left) and a vesicle
not surrounded by actin.
Table II. Quantitative Analysis of Polymerization Products
Filament length
No filaments
(unbranched/branched) Conditions unbranched branched Percent branched
mm 6 SD
Arp2/3 complex, prenylated GTPgS-Cdc42, PIP2 7.0 6 6.5 105/1 1
WASp, prenylated GTPgS-Cdc42, PIP2 6.6 6 6.2 140/1 1
Arp2/3 complex, WASp 2.6 6 1.9 125/2 2
Arp2/3 complex, PIP2 3.2 6 2.6 1.5 6 1.3 101/37 27
Arp2/3 complex, WASp, prenylated GTPgS-Cdc42 2.7 6 1.8 87/1 1
Arp2/3 complex, WASp, prenylated GTPgS-Cdc42, PIP2 7.2 6 4.1 1.5 6 1.4 127/92 42Higgs and Pollard WASp Activation of Arp2/3 Complex 1317
Effect of WASp GBD on WASp WA Activity
Our finding that native WASp does not activate Arp2/3
complex unless stimulated by PIP2 and prenylated
GTPgS-Cdc42 supports an autoinhibition mechanism for
WASp (Miki et al., 1998; Kim et al., 2000). We tested the
possibility that NH2-terminal WASp motifs bind the WA
region and prevent it from activating Arp2/3 complex us-
ing a construct of WASp (termed WAS p152-309) ex-
pressed in E. coli. This construct begins immediately after
the predicted EVH1 domain and ends just before the
polyproline region (Fig. 1 A). Thus, WASp152-309 con-
tains the entire WASp GBD as well as residues essential
for binding WASp-WA (Kim et al., 2000).
The addition of WASp152-309 to nucleation reactions
containing 0.25 mM WASp-WA and 10 nM Arp2/3 com-
plex inhibited filament production, with half-maximal in-
hibition at 3 mM (Fig. 4 A). Importantly, WASp152-309
did not inhibit nucleation by Scar1-WA and Arp2/3 com-
plex, as predicted, because residues of WASp-WA that
bind WASp GBD (Kim et al., 2000) are completely differ-
ent from the corresponding part of Scar1 WA. In a fluores-
cence anisotropy assay, WASp152-309 bound WASp-WA
with a dissociation equilibrium constant of 0.42 mM (Fig. 4
B). WAS p152-309 also inhibited binding of Arp2/3 com-
plex to rhodamine WASp-WA (Fig. 4 C), suggesting that
WAS p152-309 inhibits nucleation by interfering with
WASp-WA binding to Arp2/3 complex.
Both prenylated GTPgS-Cdc42 (Fig. 5 A) and unpren-
ylated GTPgS-Cdc42 (not shown) overcame the inhibition
Figure 4. Regulation of WASp-WA by a fragment of WASp in-
cluding the GBD. (A) WASp 152-309 inhibits Arp2/3 complex
activation by WASp WA. Nucleation reactions included 4 mM of
monomeric MgATP actin (5% pyrene-labeled), 10 nM of Arp2/3
complex, 250 nM WASp WA or Scar1 WA, and varying concen-
trations of WASp 152-309. The concentration of filament ends
created by Arp2/3 complex was calculated from the slope of the
polymerization curve at 80% polymerization. Percent nucleation
is the concentration of ends created relative to that created by
Arp2/3 complex and WASp WA or Scar1 WA in the absence of
WASp 152-309, after subtraction of the concentration of fila-
ments created in the absence of WA. (B) Binding of WASp 152-
309 to WASp WA was measured by fluorescence anisotropy of
rhodamine-labeled WASp WA (0.1 mM). The calculated dissoci-
ation equilibrium constant is 0.42 mM. (C) Fluorescence anisot-
ropy assay for competition between Arp2/3 complex and
WASp152-309 for binding WASp WA. Rhodamine-labeled
WASp WA (0.1 mM) has an anisotropy of 0.162 when bound to 1
mM of Arp2/3 complex. The smaller WASp152-309 competes off
Arp2/3 complex, giving an anisotropy of 0.132.
Figure 5. WASp152-309 interacts with GTPgS-Cdc42 but not
with PIP2. (A) Effect of GTPgS-Cdc42 and PIP2 on nucleation in-
hibition by WASp152-309. Nucleation assays were performed as
described in Fig. 2 A with 10 nM of Arp2/3 complex alone (filled
circles); Arp2/3 complex, 250 nM WASp WA (open circles);
Arp2/3 complex, WASp WA, 3 mM WASp152-309 (filled
squares); Arp2/3 complex, WASp WA, WASp152-309, 1.6 mM
prenylated GTPgS-Cdc42 (open squares); Arp2/3 complex,
WASp WA, WASp152-309, 3.2 mM prenylated GTPgS-Cdc42
(filled diamonds); and Arp2/3 complex, WASp WA, WASp152-
309, 30 mM PIP2 (open diamonds). (B) Effect of WASp152-309
on full-length native WASp activation by PIP2 and GTPgS-
Cdc42. Nucleation assays were performed as described in Fig. 2
A with 10 nM of Arp2/3 complex alone (open circles); Arp2/3
complex, 2 nM WASp (filled circles); Arp2/3 complex, WASp, 20
mM PIP2 (open squares); Arp2/3 complex, WASp, PIP2, 25 mM
WASp152-309 (filled squares); Arp2/3 complex, WASp 1 PIP2,
0.5 mM prenylated GTPgS-Cdc42 (filled triangles); and Arp2/3
complex, WASp, PIP2, prenylated GTPgS-Cdc42, 25 mM
WASp152-309 (open triangles).The Journal of Cell Biology, Volume 150, 2000 1318
of WASp-WA by WASp152-309 in the pyrene-actin nucle-
ation assay, whereas PIP2 did not reverse this inhibition.
We also tested the effect of WASp152-309 on Arp2/3 com-
plex activation by full-length WASp. WASp152-309 did
not block the effect of PIP2 on WASp, but did block the
effect of prenylated GTPgS-Cdc42 (Fig. 5 B). These re-
sults suggest that WASp152-309 might not contain the re-
gion responsive to PIP2. In support of this conclusion,
WASp152-309 did not bind to vesicles containing PIP2 or
other anionic lipids (not shown).
Discussion
This is the first study to characterize native WASp from
leukocytes in terms of its cellular fractionation, cellular
concentrations, and ability to activate Arp2/3 complex.
The concentration of WASp in human neutrophils is sur-
prisingly high (9 mM), almost equal to that of Arp2/3 com-
plex (Higgs et al., 1999). This high concentration of WASp
suggests that its ability to activate Arp2/3 complex must be
tightly regulated since, at this concentration, even a low
constitutive activity would cause significant Arp2/3 com-
plex activation.
Evidence from cell extract studies also suggests that
Arp2/3 complex activation is tightly regulated, being
strongly activated by GTP-Cdc42 and PIP2 (Zigmond et
al., 1997; Ma et al., 1998a; Mullins and Pollard, 1999).
WASp and N-WASP are leading candidates for mediators
of this activation. However, previous studies showed that
low concentrations of WASp isolated from insect cells po-
tently activated Arp2/3 complex in the absence of any acti-
vators (Yarar et al., 1999). Other studies using the
N-WASP isolated from insect cells showed considerable
constitutive Arp2/3 complex activation in the absence of
activators (Egile et al., 1999; Rohatgi et al., 1999). In the
latter two cases, the candidate WASp and N-WASP stimu-
lator, Cdc42, did increase Arp2/3 complex activation, but
surprisingly did so with both GDP- and GTP-bound in one
study (Rohatgi et al., 1999). PIP2 enhanced GTP-Cdc42
activation of N-WASP in one study (Rohatgi et al., 1999),
but was not tested by Egile et al. The combination of these
results suggests that the WASp and N-WASP expressed in
insect cells is not as tightly regulated as expected for the
activator of Arp2/3 complex.
Our results with native WASp activating Arp2/3 com-
plex differ in two ways from previous work on WASp and
N-WASP expressed in insect cells (Egile et al., 1999; Ro-
hatgi et al., 1999; Yarar et al., 1999). First, the difference in
Arp2/3 complex activation between nonactivated and fully
activated WASp is much greater in our study. Second,
PIP2 micelles alone stimulate native WASp, whereas pren-
ylated GTPgS-Cdc42 alone does not at 0.5 mM. However,
we found that prenylated GTPgS-Cdc42 increased WASp
stimulation by PIP2 twofold. Cdc42 had to be GTPgS-
bound and prenylated for this effect.
In our hands, the WASp expressed in insect cells be-
haves in a heterogeneous fashion, but the WASp from bo-
vine thymus and human neutrophils behaves much more
homogeneously. Over 90% of WASp from extracts of ei-
ther leukocyte source partitions into the 100,000-g super-
natant, indicating that the majority is not associated with
either the actin cytoskeleton or membranes under these
conditions. This also suggests that most WASp molecules
are not bound to GTP-Cdc42 or to PIP2 because both of
these ligands are associated with the membranes (Regazzi
et al., 1992; Nomanbhoy et al., 1999). Purified WASp has a
Stokes’ radius of 5.0 nm by gel filtration, and a mass of 122
kD by sedimentation equilibrium analytical ultracentrifu-
gation. Because no other bands were visible in the cleanest
WASp preparation, the size suggests that WASp is a mul-
timer, either a dimer or a trimer. The WASp multimer ap-
pears to be very stable, since only 40 nM of WASp was
used for these analytical techniques. Others have pro-
posed N-WASP to be a multimer, with a sedimentation co-
efficient of 5.45 S at 1 mM, by sedimentation velocity ana-
lytical ultracentrifugation (Carlier et al., 2000). These
authors also proposed that N-WASP is in equilibrium be-
tween monomer and multimer, and that the monomer is
the active state. Our results at 40 nM WASp suggest that
the equilibrium strongly favors the multimer. Further
work is necessary to determine the stoichiometry of the
multimer, the interfaces involved in multimerization, and
the effects of WASp activators on the multimeric state.
When stimulated by both PIP2 and prenylated GTPgS-
Cdc42, native WASp activated Arp2/3 complex much
more strongly than the constitutively active WA fragment.
WASp at 4 nM activated Arp2/3 complex almost stoi-
chiometrically, whereas 4 nM WA caused no detectable
activation. Dimeric GST-WA had an activation efficiency
similar to native WASp, and could fully activate Arp2/3
complex at a 50-fold lower concentration than WA. Dimeric
GST-WA binds actin and Arp2/3 complex with an affinity
similar to monomeric WA (Marchand, J.B., H.N. Higgs,
and T.D. Pollard, unpublished data). The multimeric state
of native WASp and GST-WA may contribute to a higher
activation efficiency, but the mechanism is not yet clear.
Our observations suggest that the synergy between PIP2
and Cdc42 is dependent on localization of both activators
on a membrane surface. PIP2 micelles or vesicles contain-
ing PIP2 or PS were foci of intense actin filament nucle-
ation in the presence of prenylated (but not unprenylated)
GTPgS-Cdc42 and native WASp. When prenylated, Cdc42
stably associates with membranes (Nomanbhoy et al.,
1999). This is similar to other particulate activators of
Arp2/3 complex including bacteria (Welch et al., 1997b),
viruses (Frischknecht et al., 1999), intracellular vesicles
(Taunton et al., 2000), beads coated with bacterial or eu-
karyotic activators of Arp2/3 complex (Cameron et al.,
1999; Yarar et al., 1999), or beads coated with Cdc42 (Ma
et al., 1998b). Others have also observed Cdc42- and PIP2-
dependent vesicle movement in whole cell extracts (Ma et
al., 1998a; Moreau and Way, 1998), although the minimum
requirements for this effect could not be determined in
these studies. Vesicles with PIP2 were more effective in
producing these actin halos than micelles of PIP2 or vesi-
cles containing PS. PIP2-containing vesicles alone promote
dendritic nucleation by native WASp and Arp2/3 complex,
but the filaments do not concentrate around vesicles. We
do not know at present whether actin filaments nucleated
by WASp and Arp2/3 complex in the presence of pren-
ylated GTPgS-Cdc42- and PIP2-containing vesicles are as-
sociated noncovalently with the vesicle surface. If WASp
binds actin filaments like N-WASP (Egile et al., 1999),
some filaments may attach by this mechanism. However,Higgs and Pollard WASp Activation of Arp2/3 Complex 1319
the actin filament halo is so thick around the vesicle that
the majority of filaments are probably not bound to the
membrane but held in place by the dendritic network
formed during nucleation by Arp2/3 complex (Blanchoin
et al., 2000).
Kim et al. (2000) proposed a mechanism for WASp reg-
ulation by GTP-Cdc42 based on earlier ideas on autoinhi-
bition (Miki et al., 1998). A nuclear magnetic resonance
structure and direct binding assays showed that WASp
GBD binds to residues 461–492 of WASp-WA. This inter-
action was proposed to block binding of WASp-WA to
Arp2/3 complex. Binding of GTP-Cdc42 to WASp GBD
was proposed to release WASp-WA, allowing it to bind
and activate Arp2/3 complex. Our experiments are consis-
tent with the main features of this model. A construct
(WASp152-309) containing the WASp GBD inhibited
WASp WA activation of Arp2/3 complex by compet-
ing with Arp2/3 complex for WA binding. GTPgS-
Cdc42 relieved inhibition by WASp152-309. Conversely,
WASp152-309 blocked enhancement of native WASp
stimulation by GTPgS-Cdc42. On the other hand, 0.5 mM
prenylated GTPgS-Cdc42 alone does not overcome auto-
inhibition of native WASp since WA binds so tightly to
WASp GBD that it reduces the affinity of the GBD for
GTP-Cdc42 by 80–300-fold (Kim et al., 2000). To be an
effective activator of WASp at a submicromolar concen-
tration, prenylated GTPgS-Cdc42 requires a membrane
containing an acidic lipid such as PIP2. However, our re-
sults do not rule out other mechanisms acting in concert
with or separately from the autoinhibition model as pro-
posed.
The PIP2 binding site on WASp is unknown. N-WASP
and WASp were originally predicted to have an NH2-ter-
minal PH domain (Miki et al., 1996), but atomic structures
revealed a polyproline binding EVH1 domain (Fedorov et
al., 1999; Prehoda et al., 1999) that overlaps, but is offset
from, the proposed PH domain. A polybasic region is
present in WASp152-309 immediately NH2-terminal to
the WASp GBD. However, WASp152-309 did not block
native WASp activation by PIP2 nor did PIP2 relieve
WASp WA inhibition by WASp152-309. Additionally,
WASp152-309 does not bind PIP2-containing vesicles.
These results suggest that WASp152-309 does not contain
the complete PIP2 binding site. Since WASp WA does not
bind PIP2 (not shown), PIP2 binding may depend on the
NH2-terminal region or the region between GBD and
WA. This site might not be specific for PIP2 since PS-con-
taining vesicles also cause actin halo formation.
The signaling pathway to WASp and Arp2/3 complex
may operate through GTP activation of Cdc42 alone in the
context of an anionic membrane surface, possibly contain-
ing PIP2, as follows. Binding to anionic lipid on the mem-
brane surface partially activates WASp, possibly by expos-
ing the acidic COOH terminus of WASp that interacts
with Arp2/3 complex. Interaction of WASp with anionic
lipid may also allow GTP-Cdc42 to bind the WASp GBD,
perhaps concentrating WASp together with prenylated
Cdc42 on the membrane surface, reducing their interac-
tion potential. Interaction with Cdc42 fully stimulates
WASp to activate Arp2/3 complex by releasing WA.
WASp binding to Cdc42 may also stabilize active WASp
on the membrane, resulting in localized actin polymeriza-
tion. Nonlipidated Cdc42 is ineffective since it does not
bind vesicles. 
Many aspects of this model remain to be tested includ-
ing the following: the PIP2 binding site on WASp; WASp
affinity for PIP2 and other lipids; the mechanism of partial
WASp activation by PIP2; and the equilibrium and rate
constants for WASp association with membranes contain-
ing PIP2 and/or Cdc42. Also, a full understanding of WASp
activation will require accurate values for cellular concen-
trations of PIP2 and GTP-Cdc42 upon cell stimulation in
addition to the knowledge of distributions of these mole-
cules in cells. The proposed synergism between GTP-
Cdc42 and PIP2, mediated by membrane binding, might
provide a mechanism for the membrane-associated actin
polymerization at the leading edge and on phagosomes/
endosomes (Merrifield et al., 1999; Taunton et al., 2000).
In addition, other WASp-binding proteins (Grb2, Nck, Src
kinases, Btk) are membrane-associated upon cell stimula-
tion, which might similarly affect WASp activation (Car-
lier et al., 2000; for review see Higgs and Pollard, 1999).
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